Company Filing History:
1 out of 4 
1 out of 2 
1 out of 3 Years Active: 2014
Title: Alessandra Mallano: A Pioneer in Antibody Derivative Innovations
Introduction
Alessandra Mallano is a prominent inventor based in Rome, Italy, recognized for her significant contributions to the field of biotechnology. With a total of two patents to her name, she has been instrumental in developing innovative solutions for the diagnosis and treatment of cancers, particularly Ewing sarcoma.
Latest Patents
One of Mallano's noteworthy patents involves antibody derivatives, specifically an anti-CEA scFv that maintains stability and high specificity for Carcinoembryonic Antigen (CEA) and CEACAM1. The longevity and specificity of this anti-CEA scFv make it a valuable asset in clinical settings. Moreover, her recent invention centers on a single-chain variable fragment (scFv) that effectively identifies and binds to the CD99 human protein. This scFv is tailored to recognize an epitope on the extracellular domain of CD99, which is expressed on Ewing sarcoma cells, offering promise in both the diagnosis and treatment of this challenging cancer.
Career Highlights
Alessandra Mallano has built her career through collaboration with esteemed institutions. She has held positions at the Instituto Superiore Di Sanita and Diatheva S.r.l., where she was able to apply her expertise in areas critical to medical advancement. Her work exemplifies the intersection between innovation and practical application in healthcare.
Collaborations
Throughout her journey as an inventor, Mallano has collaborated with notable colleagues, including Maurizio Cianfriglia and Michela Flego. These partnerships have further propelled her research and development, leading to advancements in the field of antibody derivatives and beyond.
Conclusion
In summary, Alessandra Mallano stands out as a significant figure in biotechnology innovation, particularly through her impactful patents involving antibody derivatives. With her strong academic background and collaborations within the industry, she continues to lead the way toward innovative treatments for critical health challenges, demonstrating the vital role of inventors in advancing medical science.